Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
National Vision Holdings, Inc. stock logo
EYE
National Vision
$22.36
+0.0%
$16.66
$9.56
$22.48
$1.70B1.241.88 million shs1.86 million shs
Penumbra, Inc. stock logo
PEN
Penumbra
$256.09
-1.9%
$275.40
$148.00
$310.00
$9.93B0.49451,561 shs376,544 shs
The Beauty Health Company stock logo
SKIN
Beauty Health
$1.53
-0.6%
$1.36
$0.78
$2.24
$192.77M1.17976,741 shs395,306 shs
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
National Vision Holdings, Inc. stock logo
EYE
National Vision
+3.91%+6.38%+16.29%+85.02%+66.42%
Penumbra, Inc. stock logo
PEN
Penumbra
+1.69%+1.57%-7.28%-5.36%+38.79%
The Beauty Health Company stock logo
SKIN
Beauty Health
+0.65%-3.75%-11.49%+20.31%-21.83%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
National Vision Holdings, Inc. stock logo
EYE
National Vision
3.0203 of 5 stars
2.24.00.03.32.30.80.0
Penumbra, Inc. stock logo
PEN
Penumbra
4.613 of 5 stars
3.45.00.03.71.42.51.9
The Beauty Health Company stock logo
SKIN
Beauty Health
0.2284 of 5 stars
0.80.00.00.01.53.30.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.44
Hold$17.75-20.62% Downside
Penumbra, Inc. stock logo
PEN
Penumbra
2.88
Moderate Buy$302.4018.08% Upside
The Beauty Health Company stock logo
SKIN
Beauty Health
1.67
Reduce$1.42-7.41% Downside

Current Analyst Ratings Breakdown

Latest SKIN, EYE, WGB, and PEN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetMarket Perform ➝ Market Perform$13.00 ➝ $19.00
5/12/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$14.00 ➝ $17.00
5/9/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$13.00 ➝ $17.00
5/9/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$13.00 ➝ $21.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$18.00 ➝ $20.00
5/8/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$13.00 ➝ $15.00
5/7/2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Buy
5/5/2025
The Beauty Health Company stock logo
SKIN
Beauty Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$1.50 ➝ $1.25
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$320.00 ➝ $330.00
4/24/2025
Penumbra, Inc. stock logo
PEN
Penumbra
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
(Data available from 6/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
National Vision Holdings, Inc. stock logo
EYE
National Vision
$1.82B0.97$1.70 per share13.15$10.37 per share2.16
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B8.30$2.88 per share88.86$29.99 per share8.54
The Beauty Health Company stock logo
SKIN
Beauty Health
$334.30M0.58$0.06 per share24.20$0.41 per share3.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
National Vision Holdings, Inc. stock logo
EYE
National Vision
-$28.50M-$0.33N/A82.816.51-1.40%3.44%1.40%8/6/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$1.06241.5951.122.333.41%11.14%8.40%7/29/2025 (Estimated)
The Beauty Health Company stock logo
SKIN
Beauty Health
-$29.10M-$0.41N/AN/AN/A-11.94%-67.91%-5.56%8/6/2025 (Estimated)

Latest SKIN, EYE, WGB, and PEN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
The Beauty Health Company stock logo
SKIN
Beauty Health
-$0.13-$0.08+$0.05-$0.08$63.88 million$69.60 million
5/7/2025Q1 2025
National Vision Holdings, Inc. stock logo
EYE
National Vision
$0.32$0.34+$0.02$0.18$510.30 million$510.32 million
4/23/2025Q1 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.66$0.83+$0.17$1.00$315.72 million$324.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
The Beauty Health Company stock logo
SKIN
Beauty Health
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
National Vision Holdings, Inc. stock logo
EYE
National Vision
0.29
0.54
0.35
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.30
3.68
The Beauty Health Company stock logo
SKIN
Beauty Health
12.01
7.47
6.43

Institutional Ownership

CompanyInstitutional Ownership
National Vision Holdings, Inc. stock logo
EYE
National Vision
N/A
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
The Beauty Health Company stock logo
SKIN
Beauty Health
93.26%

Insider Ownership

CompanyInsider Ownership
National Vision Holdings, Inc. stock logo
EYE
National Vision
2.70%
Penumbra, Inc. stock logo
PEN
Penumbra
5.00%
The Beauty Health Company stock logo
SKIN
Beauty Health
41.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
National Vision Holdings, Inc. stock logo
EYE
National Vision
13,41179.05 million76.92 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50038.73 million36.79 millionOptionable
The Beauty Health Company stock logo
SKIN
Beauty Health
1,030125.99 million74.34 millionOptionable

Recent News About These Companies

Best Skin-Care Products for Black Skin
Dr. Bexi Lobo: Is your skin care self-care?
Double cleansing might be ruining your perfect skin
Unearthing the secrets of carrot seed oil for healthy skin
5 tips to nourish skin and hair naturally

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
National Vision stock logo

National Vision NASDAQ:EYE

$22.36 +0.01 (+0.04%)
Closing price 04:00 PM Eastern
Extended Trading
$22.10 -0.25 (-1.14%)
As of 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

Penumbra stock logo

Penumbra NYSE:PEN

$256.09 -4.88 (-1.87%)
Closing price 03:59 PM Eastern
Extended Trading
$253.58 -2.50 (-0.98%)
As of 04:43 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Beauty Health stock logo

Beauty Health NASDAQ:SKIN

$1.53 -0.01 (-0.65%)
Closing price 04:00 PM Eastern
Extended Trading
$1.51 -0.02 (-1.31%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.